Pharma companies in Maharashtra have been suffering losses to the tune of Rs 4 crore per day ever since the Maharashtra Food and Drug Administration (FDA) enforced a ban on exports of pharma products through parcel posts in February this year, IPDA president Sunil Phalke and secretary Navneet Sahay told reporters here today.
IPDA, which represents more than 50 pharma manufacturers and exporters, has asked the Maharashtra government to immediately intervene to stop harassment of law abiding pharma companies in the state under the pretext of curbing "clandestine activities," Sahay said.
The biggest negative impact of banning exports through parcel posts has been on e-commerce trade of pharmaceuticals, which has completely crashed after the ban was clamped four months ago, since parcel post is used to export consignments of less than five kilogrammes.
An IPDA delegation is scheduled to meet Union Minister for Commerce Nirmala Sitaraman in New Delhi tomorrow, IPDA sources said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
